Cargando…

Leveraging NKG2D Ligands in Immuno-Oncology

Immune checkpoint inhibitors (ICI) revolutionized the field of immuno-oncology and opened new avenues towards the development of novel assets to achieve durable immune control of cancer. Yet, the presence of tumor immune evasion mechanisms represents a challenge for the development of efficient trea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fuertes, Mercedes Beatriz, Domaica, Carolina Inés, Zwirner, Norberto Walter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358801/ https://www.ncbi.nlm.nih.gov/pubmed/34394116 http://dx.doi.org/10.3389/fimmu.2021.713158

Ejemplares similares

The MICA-NKG2D axis in clear cell renal cell carcinoma bolsters MICA as target in immuno-oncology
por: Secchiari, Florencia, et al.
Publicado: (2022)

Circulating and Tumor-Infiltrating NK Cells From Clear Cell Renal Cell Carcinoma Patients Exhibit a Predominantly Inhibitory Phenotype Characterized by Overexpression of CD85j, CD45, CD48 and PD-1
por: Ziblat, Andrea, et al.
Publicado: (2021)

Cutting an NKG2D Ligand Short: Cellular Processing of the Peculiar Human NKG2D Ligand ULBP4
por: Zöller, Tobias, et al.
Publicado: (2018)

NKG2D/NKG2-Ligand Pathway Offers New Opportunities in Cancer Treatment
por: Frazao, Alexandra, et al.
Publicado: (2019)

How Mucosal Epithelia Deal with Stress: Role of NKG2D/NKG2D Ligands during Inflammation
por: Antonangeli, Fabrizio, et al.
Publicado: (2017)

Molecular Bases for the Regulation of NKG2D Ligands in Cancer
por: Huergo-Zapico, Leticia, et al.
Publicado: (2014)

Interleukin (IL)-23 Stimulates IFN-γ Secretion by CD56(bright) Natural Killer Cells and Enhances IL-18-Driven Dendritic Cells Activation
por: Ziblat, Andrea, et al.
Publicado: (2018)

NKG2D and Its Ligands: “One for All, All for One”
por: Zingoni, Alessandra, et al.
Publicado: (2018)

Editorial: The interaction of NKG2D and its ligands in health and diseases
por: Gaudieri, Silvana, et al.
Publicado: (2022)

NKG2D Ligands in Tumor Immunity: Two Sides of a Coin
por: Zhang, Jinyu, et al.
Publicado: (2015)

The Biological Influence and Clinical Relevance of Polymorphism Within the NKG2D Ligands
por: Zuo, Jianmin, et al.
Publicado: (2018)

NKG2D Ligands–Critical Targets for Cancer Immune Escape and Therapy
por: Schmiedel, Dominik, et al.
Publicado: (2018)

NKG2D Ligand Shedding in Response to Stress: Role of ADAM10
por: Zingoni, Alessandra, et al.
Publicado: (2020)

Human Natural Killer Cell Maturation Defect Supports In Vivo CD56(bright) to CD56(dim) Lineage Development
por: Domaica, Carolina Inés, et al.
Publicado: (2012)

Natural Killer Group 2, Member D/NKG2D Ligands in Hematopoietic Cell Transplantation
por: Carapito, Raphael, et al.
Publicado: (2017)

Manipulation of NKG2D Ligands by Cytomegaloviruses: Impact on Innate and Adaptive Immune Response
por: Slavuljica, Irena, et al.
Publicado: (2011)

Human NKG2D-ligands: cell biology strategies to ensure immune recognition
por: Fernández-Messina, Lola, et al.
Publicado: (2012)

Editorial: Emerging Concepts on the NKG2D Receptor-Ligand Axis in Health and Diseases
por: Guerra, Nadia, et al.
Publicado: (2020)

Increased serum NKG2D-ligands and downregulation of NKG2D in peripheral blood NK cells of patients with major burns
por: Haik, Josef, et al.
Publicado: (2015)

New Insights Into the Regulation of Natural-Killer Group 2 Member D (NKG2D) and NKG2D-Ligands: Endoplasmic Reticulum Stress and CEA-Related Cell Adhesion Molecule 1
por: Hosomi, Shuhei, et al.
Publicado: (2018)

The Role of NKG2D in Vitiligo
por: Plaza-Rojas, Lourdes, et al.
Publicado: (2021)

Mevalonate Metabolism in Immuno-Oncology
por: Gruenbacher, Georg, et al.
Publicado: (2017)

Disarming Cellular Alarm Systems—Manipulation of Stress-Induced NKG2D Ligands by Human Herpesviruses
por: Schmiedel, Dominik, et al.
Publicado: (2017)

Cytoplasmic Citrate Flux Modulates the Immune Stimulatory NKG2D Ligand MICA in Cancer Cells
por: Møller, Sofie H., et al.
Publicado: (2020)

Corrigendum: The Role of NKG2D in Vitiligo
por: Plaza-Rojas, Lourdes, et al.
Publicado: (2021)

New prospects on the NKG2D/NKG2DL system for oncology
por: Ullrich, Evelyn, et al.
Publicado: (2013)

The Role and Regulation of the NKG2D/NKG2D Ligand System in Cancer
por: Tan, Ge, et al.
Publicado: (2023)

The NKG2D/NKG2DL Axis in the Crosstalk Between Lymphoid and Myeloid Cells in Health and Disease
por: Stojanovic, Ana, et al.
Publicado: (2018)

Manipulating the NKG2D Receptor-Ligand Axis Using CRISPR: Novel Technologies for Improved Host Immunity
por: Alves, Eric, et al.
Publicado: (2021)

Functional Characterisation and Analysis of the Soluble NKG2D Ligand Repertoire Detected in Umbilical Cord Blood Plasma
por: Cox, Steven T., et al.
Publicado: (2018)

The Paradoxical Role of NKG2D in Cancer Immunity
por: Sheppard, Sam, et al.
Publicado: (2018)

Role of Polymorphisms of NKG2D Receptor and Its Ligands in Acute Myeloid Leukemia and Human Stem Cell Transplantation
por: Machuldova, Alena, et al.
Publicado: (2021)

NKG2D and Its Ligand MULT1 Contribute to Disease Progression in a Mouse Model of Multiple Sclerosis
por: Legroux, Laurine, et al.
Publicado: (2019)

MICAgen Mice Recapitulate the Highly Restricted but Activation-Inducible Expression of the Paradigmatic Human NKG2D Ligand MICA
por: Kim, Younghoon, et al.
Publicado: (2020)

Corrigendum: Functional Characterisation and Analysis of the Soluble NKG2D Ligand Repertoire Detected in Umbilical Cord Blood Plasma
por: Cox, Steven T., et al.
Publicado: (2020)

The HHV-6A Proteins U20 and U21 Target NKG2D Ligands to Escape Immune Recognition
por: Chaouat, Abigael Eva, et al.
Publicado: (2021)

A Herpesviral induction of RAE-1 NKG2D ligand expression occurs through release of HDAC mediated repression
por: Greene, Trever T, et al.
Publicado: (2016)

Reovirus infection of tumor cells reduces the expression of NKG2D ligands, leading to impaired NK-cell cytotoxicity and functionality
por: Khaleafi, Raghad, et al.
Publicado: (2023)

MICA and NKG2D: Is There an Impact on Kidney Transplant Outcome?
por: Risti, Matilde, et al.
Publicado: (2017)

Bispecific NKG2D-CD3 and NKG2D-CD16 Fusion Proteins as Novel Treatment Option in Advanced Soft Tissue Sarcomas
por: Hagelstein, Ilona, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rgonnfv5nogq2t9e7suft4uh8j